Skip to main content
Clinical Trials/NCT05225649
NCT05225649
Completed
Not Applicable

Pilot Randomized Controlled Trial to Reduce Obesity Risk Factors During the First 1,000 Days

Columbia University1 site in 1 country50 target enrollmentStarted: January 14, 2022Last updated:
ConditionsObesity, Infant

Overview

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Arm specific retention rates at 18 months

Overview

Brief Summary

Specific Aim: Feasibility of a Pilot Randomized Controlled Trial (RCT) in Pregnancy and Infancy to Reduce Childhood Obesity Risk Factors in Early Life.

The main outcomes are feasibility of the intervention components and data collection. Study will use maternal body mass index (BMI) and child weight-for-length outcomes to estimate sample size needed for a full-scale trial to test intervention efficacy. Primary analysis for full-scale trial power and sample size calculations will be conducted using child weight-for-length data at Child Age 12 Months Visit. Data collected will inform future interventions.

Detailed Description

Early life interventions to prevent childhood obesity among disproportionately burdened populations are needed to reduce childhood obesity.

The overall goal of this study is to test the feasibility of a pilot randomized controlled trial to promote healthy maternal weight in pregnancy and post-partum and normal child weight-for-length from birth to age 12 months. The study will include 50 women (enrollment up to 70 to account for potential attrition) in pregnancy and their child through age 12 months to examine rates of study component completion, study component satisfaction, and retention. Women enrolled in the intervention will participate in virtual health coaching and receive self-directed behavior change materials by text and email. The results of this study will help us develop efficacious childhood obesity prevention interventions and determine how many study participants would be needed for a full-scale trial. Ultimately, this research could open new avenues for studying ways to promote health starting early in life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Triple (Care Provider, Investigator, Outcomes Assessor)

Masking Description

Participants will be identified by a participant code to the care provider, investigator, and outcomes assessor until primary analysis is complete.

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 18-50 years at time of enrollment
  • Gestational age 10-20 weeks at time of enrollment
  • Receiving primary care or prenatal care at Columbia/New-York Presbyterian site
  • Planned delivery at Columbia/New-York Presbyterian with planned continuation of primary care (postpartum and pediatric) at Columbia/New-York Presbyterian
  • Ability to read and respond to questions in English or Spanish
  • Smart phone ownership
  • Willingness to receive information by smart phone for 18-month intervention and follow-up duration
  • Willingness to be randomized into an observational study or an intervention and complete all study components
  • Gives permission to participate in receiving messages to their smart phone and email
  • Gives permission to complete all study procedures

Exclusion Criteria

  • Multiple gestation
  • Pre-pregnancy body mass index \<18.5 kg/m2 \>40
  • Major fetal anomaly
  • Fetal genetic abnormality
  • Planned termination of pregnancy
  • Chronic medical conditions that affect nutrition or prohibit regular exercise or alter weight status such as:
  • Diseases associated with glucose metabolism
  • Diabetes (Type 1, type 2)
  • Inflammatory Bowel Disease (Crohn's disease, ulcerative colitis)
  • History of gastric bypass/gastric sleeve

Outcomes

Primary Outcomes

Arm specific retention rates at 18 months

Time Frame: Up to 18 months

The retention rate will be defined as the proportion of enrolled individuals who complete infant age 12-months study visits (study month 18) according to each arm.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials